Author

Elena B. Kabotyanski

Baylor College of Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Na ZhaoiD· 2 shared Alex J. SmithiD· 1 shared Alexander B. SaltzmaniD· 1 shared Alison A. BertuchiD· 1 shared Anna MalovannayaiD· 1 shared Anthony R. SancheziD· 1 shared Bing ZhangiD· 1 shared Charles M. PerouiD· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Na ZhaoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologybioRxivPreprintOct 10, 2024

RPS19 and RPL5, the most commonly mutated genes in Diamond Blackfan anemia, impact DNA double-strand break repair

Nicholas F. DeCleene, Elif Aşık, Anthony R. Sanchez…·Alison A. Bertuch

This study shows that RPS19 and RPL5 mutations in DBA impair DNA double-strand break repair, potentially explaining cancer risk in patients.

2 citations

humanDNA methylation

𝕏 PostBluesky

Cancer BiologyJournal of Clinical InvestigationPeer-reviewedOct 24, 2023

Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer

Na Zhao, Elena B. Kabotyanski, Alexander B. Saltzman…·Jeffrey M. Rosen

Zotatifin targets EIF4A to suppress TNBC by inhibiting Sox4, inducing interferon response, and reprogramming the tumor immune microenvironment, synergizing with chemotherapy.

34 citationstop 4%

mousebulk RNA-seq

𝕏 PostBluesky